#TriviaTuesday Which is the best test for assessing iron stores? Review the table below ⤵️ 🖥️: coreimpodcast.com/2024/03/13/iro…

Jeff Bezos dropped the most underrated winning principle

Jasprit Bumrah on dropped catches “I am disappointed for a second when catches are dropped. It’s part and parcel of the game, and the guys are new and working so hard. I don’t want to create a scene and put more pressure on them. Nobody is doing it intentionally, so they will

Thrilled and grateful to have received the Young Investigator scholarship (YIP) award from Society of Hematologic Oncology (SOHO) for #SOHO25 ! Thankful and grateful for the help and support from Prashanth Ashok Kumar SUNY Upstate IM Residency Upstate Cancer Center Nikhil Vojjala, MD Avi Harisingani, MD

🩸 Excited to share our work at International Society on Thrombosis and Haemostasis (ISTH) #ISTH2025 ISTH in Washington, DC! 📍Poster PB0518 🦵🏽🎈Thrombotic Outcomes in Pancreatic Cancer Patients on Pembrolizumab vs. Erlotinib 💡 Our real-world data shows pembrolizumab is

📢 Excited to share our multicenter study just published in Clinical Lymphoma, Myeloma & Leukemia: “Real-world outcomes of sequential BCMA therapies in RRMM after belantamab” 🔗 clinical-lymphoma-myeloma-leukemia.com/article/S2152-… Shout-out to Hamza Hashmi Racheldileo With: Yue Yin Christopher Strouse

steve jobs: "you can't plan to meet the people who will change your life"

Great leaders think like farmers.

1/ 🚨 NEW #BeyondJournalClub w/ NEJM Group: REDUCE-AMI What is the long term benefit of beta blockers in patients with preserved EF following an MI?

🖥️: coreimpodcast.com/2025/06/25/bet…

🚨 Global Oncology Has a New Home 🌍 Introducing The OncoWisdom Circle — a global WhatsApp community built for oncologists, by oncologists. 🎯 Designed for: 👨‍⚕️ Fellows 👩‍⚕️ Practicing Oncologists 🎓 Tumor-type Experts 📂 Organized into 12 focused subgroups: 🧠 Tumor-type forums 📖

🚨 Major congratulations! 🚨 Dr. Joseph McGuirk, Division Director of Hematologic Malignancies & Cellular Therapeutics, has been awarded the prestigious 2025 KCU Alumni Lifetime Achievement Award! A true pioneer in CAR T therapy and Malignant Hematology — well deserved! 👏🎉

What’s up with Beta 2 microglobulin (B2M) and myeloma? Why is it the sole non-cytogenetic marker used in the new IMWG high risk definition? Why does it matter whether the creatinine is high or not? Thread 1/

Dr. Rami Komrokji is personally inviting YOU to #SOHO2025. Don't let him down. Register today at soho.click/2025. 💯 Rami komrokji

👏 I saw an interesting anecdote and just looked up the reference. Literally before I was born, an oncologist very succinctly and elegantly summarized how we offer hope to our patients living with cancer... these words are still true today! pubmed.ncbi.nlm.nih.gov/18750361/

Exercise therapy and self-management support for individuals with multimorbidity: a randomized and controlled trial. nature.com/articles/s4159… nature Nature Portfolio Nature Medicine #Exercise #Geriatrics #MedTwitter

🚀 Officially submitted my ERAS application for the 2026 Hematology/Oncology Fellowship Match! Grateful for the mentors, patients, and friends who’ve shaped this journey. Looking forward to the next chapter in cancer care, equity, and innovation. 🙏🏽✨ 📋 AAMC ID: 14490577

So you have learnt how to critically appraise the literature… How you use those skills is important. The goal should not be to display one’s critical appraisal skills. This is not a contest. We can find flaws in every trial. If you did a trial, chances are when it’s published

Program Director’s Note - Personal Statement Pitfalls A #ProgramDirectorsNote to my Yale IM Traditional Residency Program residents now that fellowship applications are in. My Yale Internal Medicine are great writers, but there are always pitfalls to avoid. open.substack.com/pub/siegelmark…

1/ 🚨 NEW #WhiteboardAnimation: Cardiorenal syndrome part ✌️ Build your diuretic resistance toolkit to master sequential nephron blockade 🛑 🖥️: coreimpodcast.com/2025/07/30/car… 🎥: youtube.com/watch?v=Ffif1M…